Sally A. Ferguson|Laura Trupin|Jinoos Yazdany|Edward H. Yelin|Jennifer Barton|Patricia Katz
Who receives contraception counseling when starting new lupus medications? The potential roles of race, ethnicity, disease activity, and quality of communication
University of California, San Francisco|University of California, San Francisco|University of California, San Francisco|University of California, San Francisco|Portland VA Medical Center|University of California, San Francisco
objective family planning discussions important aspect medical care women systemic lupus erythematosus sle active disease risk factor poor pregnancy outcomes medications used treatment harmful fetus used conception pregnancy objective examine impact patient perception quality type communication receiving contraception counseling methods data derived patients enrolled university california san francisco lupus outcomes study individuals participate yearly structured telephone interview includes assessment contraception counseling starting new medications measures communication decision making logistic regression performed identify predictors receiving contraception counseling results 68 women included analysis onethird receive contraception counseling starting new medications older age white race depressive symptoms higher sle disease activity independently associated receiving contraception counseling participants receive contraception counseling rated physicians lower shared decisionmaking sdm communication conclusions study demonstrates gap family planning counseling among women sle starting new medications future studies address potential areas intervention including education need contraception menopause mechanisms engage sdm surrounding contraception needed improve quality care women lupus